A Study to Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA
Clinical trial NCT03124498 · UNKNOWN
Trial details
- NCT number
- NCT03124498
- Sponsor
- Chuan An Biotechnology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-01
- Primary completion
- 2019-06-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.